Immersive Virtual Reality Satisfies the Women in Labor by Distracting Them From Their Labor Pain in Labor on Latent and Active Phase
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05032456 |
Recruitment Status :
Completed
First Posted : September 2, 2021
Last Update Posted : September 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Labor Pain | Device: Oculus Quest All-in-one VR Gaming Headset (128 GB) VR system | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 42 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Intervention Model Description: | 42 laboring women allocated to intervention group and control group randomly |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Immersive Virtual Reality Improves Satisfaction In Laboring Women |
Actual Study Start Date : | November 13, 2020 |
Actual Primary Completion Date : | June 10, 2021 |
Actual Study Completion Date : | June 14, 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Virtual Reality Group
Investigators used Oculus Quest All-in-one Virtual Reality Gaming Headset (128 GB) VR system. Before the intervention, the investigators introduced the equipment and instructed study participants on how to wear and activate the headsets. The laboring women who enrolled in the virtual reality group first wore the headsets in early labor (Cervical dilation 3 cm) for 20 minutes. The patients were offered to choose among several virtual environments including orange sunset, green meadows, black beginning, red savannah, blue deep, blue moon, blue ocean, white winter, and red fall. Cards printed out from the images of the Nature Trek application representing these novel immersion options were provided to the patients to help them pick up their preferred environment in advance. The second implementation of virtual reality headsets was after the epidural analgesia in the active phase of labor for another 20 minutes (Cervical dilation 6-7cm).
|
Device: Oculus Quest All-in-one VR Gaming Headset (128 GB) VR system
The laboring women who enrolled in the VR group were offered to choose among several virtual environments including orange sunset, green meadows, black beginning, red savannah, blue deep, blue moon, blue ocean, white winter, and red fall. Cards printed out from the screenshots of the Nature Trek application representing these novel immersion options were provided to the patients to help them pick up their preferred environment in advance. |
No Intervention: Control Group
For participants randomized to the control group, virtual reality headsets were not used and the clinic's standard of care in laboring women was followed. Participants in this group filled out a visual pain rating scale both in the latent and active phases of labor.
|
- Virtual Reality Satisfaction Survey [ Time Frame: During the intervention ]Patient satisfaction with the use of VR was assessed by a "Virtual Reality Satisfaction Survey" 10 question survey prepared by our team: 0 being the lowest and 100 being the highest possible VR satisfaction score.
- Wong-Baker Faces Pain [ Time Frame: During the intervention ]Pain scores both in early and active labor in each group were assessed using Wong-Baker Faces Pain Rating Scale. The scale shows a series of 6 faces ranging from a happy face at 0, or "no hurt", to a crying face at 5, which represents "hurts like the worst pain
- Visual Analog Scale (VAS) [ Time Frame: A week after the labor ]Patient satisfaction with overall labor and delivery experience was assessed using a Visual Analog Scale (VAS). Zero indicates the most negative experience possible and 10 indicates the highest satisfaction possible.
- Beck Anxiety Inventory (BAI) [ Time Frame: Pre-intervention, on admission ]Anxiety levels of study participants were assessed with Beck Anxiety Inventory (BAI). [19] This inventory consists of 21 items, each scored from 0 to 3. This is a self-report questionnaire measuring somatic and cognitive parts of anxiety. The total score is calculated by finding the sum of 21 items. A score of 0 to 7 indicates minimal anxiety, 8 to 15 mild anxiety, 16 to 25 moderate anxiety, and 30 to 63 is associated with severe anxiety.
- Beck Depression Inventory (BDI) [ Time Frame: Pre-intervention, on admission ]It consists of 21 items which is a multiple-choice test and give a score ranging from 0 to 63. Each answer is scored on a scale value of 0-3. Measures of 0-9 indicate that a person is not depressed, 10-18 indicates mild-moderate depression, 19-29 indicates moderate-severe depression and 30-63 indicates severe depression.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 42 Years (Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Being female and having singleton pregnancy at 37-41 weeks gestation |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18-42 years of age
- 37-41 week gestation
- A singleton pregnancy
- With vertex presentation
- No history of chronic medical conditions
- Absence of pregnancy complications
- Admission with documented labor by cervical exam and regular uterine contractions.
Exclusion Criteria:
- Migraine
- Headache
- Dizziness
- Motion Sickness
- Epilepsy
- Psychiatric disorders
- Visual or auditory disabilities
- History of cesarean section

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05032456
Turkey | |
Acibadem Maslak Hospital | |
Istanbul, Sariyer, Turkey, 34457 |
Documents provided by Assoc. Prof. Dr. Selen Gür Özmen MD Phd, Bahçeşehir University:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Assoc. Prof. Dr. Selen Gür Özmen MD Phd, Assoc.Prof. Dr. Selen Gür Özmen, Bahçeşehir University |
ClinicalTrials.gov Identifier: | NCT05032456 |
Other Study ID Numbers: |
2020-18/07 |
First Posted: | September 2, 2021 Key Record Dates |
Last Update Posted: | September 2, 2021 |
Last Verified: | August 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Labor Immersive Virtual Reality Non-pharmacologic Treatment Anxiety Depression |
Labor Pain Pain Neurologic Manifestations |